---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-015041"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2023-05-01T23:59:59+00:00"
generated_at: "2026-06-16T04:36:10.310616+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cassava Sciences terminates $100M SVB ATM, enters $200M ATM with JonesTrading

## Summary
- Terminated SVB Securities ATM agreement effective May 1, 2023; no shares ever sold under that facility.
- Entered new Capital on Demand Sales Agreement with JonesTrading for up to $200M aggregate offering price.
- New ATM replaces prior program; shares sold via 'at the market' offerings under new shelf registration statement S-3.
- JonesTrading receives commission up to 3% of gross proceeds; company reimburses certain expenses.
- No obligation to sell shares; company can set minimum price and suspend or terminate offering.

## SEC filing metadata
- accession: 0001493152-23-015041
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2023-05-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.02, 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000149315223015041/0001493152-23-015041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000149315223015041/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-015041
- JSON: https://secwatch.observer/filing/0001493152-23-015041.json
- Plain text: https://secwatch.observer/filing/0001493152-23-015041.txt

## Key facts
- Material Agreements
  FILANA THERAPEUTICS, INC. terminated SVB Sales Agreement with SVB Securities LLC (f/k/a SVB Leerink LLC) valued at up to $100,000,000 (effective 2023-05-01).
  - Action: termination
  - Agreement: atm program
  - Counterparty: SVB Securities LLC (f/k/a SVB Leerink LLC)
  - Value: up to $100,000,000
  - Effective: 2023-05-01
  source text: On April 26, 2023, the Company provided SVB with notice of termination of the SVB Sales Agreement, effective May 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069530/000149315223015041/0001493152-23-015041-index.htm
- Material Agreements
  FILANA THERAPEUTICS, INC. entered into Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC valued at up to $200,000,000 (effective 2023-05-01).
  - Action: entry
  - Agreement: atm program
  - Counterparty: JonesTrading Institutional Services LLC
  - Value: up to $200,000,000
  - Effective: 2023-05-01
  source text: On May 1, 2023, the Company entered into a Capital on DemandTM Sales Agreement (the “Sales Agreement”) with JonesTrading Institutional Services LLC, as agent (“Agent”), pursuant to which the Company may offer and sell, from time to time through or to the Agent, shares of the Company’s common stock, par value $0.001 per share (the “Shares”), having an aggregate offering price of up to $200,000,000 (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069530/000149315223015041/0001493152-23-015041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.